source
- FDA approves Ionis’ Zanvastro as first disease-modifying therapy for Alexander diseaseThe U.S. Food and Drug Administration has granted approval to Ionis Pharmaceuticals' antisense oligonucleotide Zanvastro, the first therapy that modifies disease progression for Alexander disease.…
- Ionis secures FDA approval for Zanvastro, first disease-modifying therapy for rare Alexander diseaseIonis Pharmaceuticals announced that the U.S. Food and Drug Administration has approved Zanvastro, marking the first disease-modifying treatment for Alexander disease, a rare and often fatal neurol…